⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25244640 | 0.68 | — | — | |
| SCHEMBL29634811 | 0.68 | — | — | |
| SCHEMBL22220380 | 0.68 | — | — | |
| SCHEMBL25376794 | 0.68 | — | — | |
| SCHEMBL30969487 | 0.67 | NR4A2 (0.37) | — | |
| SCHEMBL27294793 | 0.67 | NR4A2 (0.37) | — | |
| SCHEMBL18109473 | 0.67 | TLR8 (0.31) | — | |
| SCHEMBL1323446 | 0.67 | ALDH1A1 (0.50) | — | |
| SCHEMBL30519495 | 0.67 | ALDH1A1 (0.50) | — | |
| SCHEMBL7940096 | 0.66 | SMN1; SMN2 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119060049-A | Pyridopyrimidine derivatives serving as small GTPase KRAS mutation inhibitors | 思路迪生物医药(上海)有限公司 | 2024-12-03 | — | — | CN | disclosed |
| CN-118215663-A | Pyridopyrimidine derivatives serving as small GTPase KRAS mutation inhibitors | 思路迪生物医药(上海)有限公司 | 2024-06-18 | — | — | CN | disclosed |
| US-20230365595-A1 | INHIBITORS OF KRAS(G12D) | RANOK THERAPEUTICS (HANGZHOU) CO. LTD. (CN) | 2023-11-16 | — | — | US | disclosed |
| US-20230365595-A1 | INHIBITORS OF KRAS(G12D) | RANOK THERAPEUTICS (HANGZHOU) CO. LTD. (CN) | 2023-11-16 | — | — | US | disclosed |
| WO-2023098832-A1 | PYRIDOPYRIMIDINE DERIVATIVES SERVING AS SMALL GTP ENZYME KRAS MUTATION INHIBITORS | 思路迪生物医药(上海)有限公司 | 2023-06-08 | — | — | WO | disclosed |